AMD begins quietly, as cells in the retina, which converts light into signals for the brain, start to deteriorate. Over time, ...
The Valeda therapy is the first ever authorized treatment by the FDA for vision loss in dry AMD patients. Valeda provides an ...
The team compared VEGF and ANGPTL4 levels in the eye fluid of 52 patients with wet AMD at various stages of anti-VEGF treatment.
Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize ...
Science Corporation says its retinal implant restored central vision in patients who were legally blind in a clinical trial.
Two posters on display will show that artificial intelligence (AI)-powered home monitoring makes a meaningful impact in the care of AMD patients by optometrists. In the first poster, Retinal ...
The Valeda therapy is the first ever authorized treatment by the FDA for vision loss in dry AMD patients. Valeda provides an improvement in best corrected visual acuity (BCVA) over 24 months of >5 ...